ArticleVemurafenib-Induced Plantar HyperkeratosisAuthor:Paul M. BedocsPublish date: September 27, 2018Vemurafenib, a selective BRAF inhibitor, is a chemotherapeutic agent used in the treatment of metastatic melanoma with BRAF mutations. It has been ...Read More
